Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis

Antonio Pinto, Vincenza Calvaruso, Salvatore Petta, Antonino Tuttolomondo, Vito Di Marco, Stefania Grimaudo, Rosaria Maria Pipitone, Anna Licata, Antonio Craxi, Calogero Camma', Marcello Ciaccio, Luca Rinaldi, Riccardo Nevola, Anna Ludovica Fracanzani, Aldo Marrone, Luca Valenti, Silvia Fargion, Luigi Elio Adinolfi, Daniele Torres, Francesca RiniRosalia Caldarella

Risultato della ricerca: Article

39 Citazioni (Scopus)

Abstract

Recent studies suggest an association between HCV infection and cardiovascular damage, including carotid atherosclerosis, with a possible effect of HCV clearance on cardiovascular outcomes. We aimed to examine whether HCV eradication by direct antiviral agents (DAA) improves carotid atherosclerosis in HCV-infected patients with advanced fibrosis/compensated cirrhosis.
Lingua originaleEnglish
Numero di pagine0
RivistaJournal of Hepatology
Stato di pubblicazionePublished - 2018

All Science Journal Classification (ASJC) codes

  • Hepatology

Fingerprint Entra nei temi di ricerca di 'Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis'. Insieme formano una fingerprint unica.

  • Cita questo